Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 14;28(2):850.
doi: 10.3390/molecules28020850.

Sericultural By-Products: The Potential for Alternative Therapy in Cancer Drug Design

Affiliations
Review

Sericultural By-Products: The Potential for Alternative Therapy in Cancer Drug Design

Gabriela-Maria Baci et al. Molecules. .

Abstract

Major progress has been made in cancer research; however, cancer remains one of the most important health-related burdens. Sericulture importance is no longer limited to the textile industry, but its by-products, such as silk fibroin or mulberry, exhibit great impact in the cancer research area. Fibroin, the pivotal compound that is found in silk, owns superior biocompatibility and biodegradability, representing one of the most important biomaterials. Numerous studies have reported its successful use as a drug delivery system, and it is currently used to develop three-dimensional tumor models that lead to a better understanding of cancer biology and play a great role in the development of novel antitumoral strategies. Moreover, sericin's cytotoxic effect on various tumoral cell lines has been reported, but also, it has been used as a nanocarrier for target therapeutic agents. On the other hand, mulberry compounds include various bioactive elements that are well known for their antitumoral activities, such as polyphenols or anthocyanins. In this review, the latest progress of using sericultural by-products in cancer therapy is discussed by highlighting their notable impact in developing novel effective drug strategies.

Keywords: 3D models; biomaterials; cancer therapy; mulberry; silk fibroin; silkworms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
B. mori’s applicability in biomedicine (Created with BioRender.com, accessed on 23 November 2022)).
Figure 2
Figure 2
Silk fibroin-based biomaterials (Created with BioRender.com, accessed on 23 November 2022)).
Figure 3
Figure 3
Main bioactive compounds in the mulberry (Created with BioRender.com, accessed on 23 November 2022).

Similar articles

Cited by

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Zhou B., Zang R., Zhang M., Song P., Liu L., Bie F., Peng Y., Bai G., Gao S. Worldwide Burden and Epidemiological Trends of Tracheal, Bronchus, and Lung Cancer: A Population-Based Study. EBioMedicine. 2022;78:103951. doi: 10.1016/j.ebiom.2022.103951. - DOI - PMC - PubMed
    1. Didkowska J., Wojciechowska U., Michalek I.M., Caetano dos Santos F.L. Cancer Incidence and Mortality in Poland in 2019. Sci. Rep. 2022;12:10875. doi: 10.1038/s41598-022-14779-6. - DOI - PMC - PubMed
    1. Zugazagoitia J., Guedes C., Ponce S., Ferrer I., Molina-Pinelo S., Paz-Ares L. Current Challenges in Cancer Treatment. Clin. Ther. 2016;38:1551–1566. doi: 10.1016/j.clinthera.2016.03.026. - DOI - PubMed
    1. Gammon J.M., Dold N.M., Jewell C.M. Improving the Clinical Impact of Biomaterials in Cancer Immunotherapy. Oncotarget. 2016;7:15421. doi: 10.18632/oncotarget.7304. - DOI - PMC - PubMed